TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

PLANO PHARMS

Infectious DiseaseDermatology
Pharma

PLANO PHARMS is a pharmaceutical company focused on Infectious Disease, Dermatology. Key products include VANCOMYCIN HYDROCHLORIDE.

2010
Since
3
Drugs
-
Trials
20
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

HEPARIN SODIUM 2026-02-20
Labeling
HEPARIN SODIUM 2026-02-20
Labeling
VANCOMYCIN HYDROCHLORIDE 2025-10-02
HEPARIN SODIUM 2025-09-24
Labeling
VANCOMYCIN HYDROCHLORIDE 2025-05-29
Labeling
HEPARIN SODIUM 2025-05-27
Labeling
HEPARIN SODIUM 2025-05-27
Labeling
HEPARIN SODIUM 2025-04-09
Labeling
VANCOMYCIN HYDROCHLORIDE 2025-03-21
HEPARIN SODIUM 2025-02-04
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 50%
1 drugs
Dermatology 50%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

Pfizer big-pharma
Infectious Disease, Dermatology
Baxter specialty
Infectious Disease, Dermatology
B BRAUN specialty
Infectious Disease, Dermatology
COSETTE other
Dermatology, Infectious Disease
BAUSCH AND LOMB specialty
Infectious Disease, Dermatology